Master One Thing - Rapamycin Longevity Series cover image

Joan Mannick on Rapamycin Longevity Series | Turning down mTOR to young levels may be good for aging

Master One Thing - Rapamycin Longevity Series

00:00

Detecting TORC2 Inhibition Clinically

Joan says rising blood lipids and triglycerides indicate unwanted TORC2 inhibition and metabolic side effects.

Play episode from 18:32
Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app